KKR Buys Contract Research Firm PRA | Chemical & Engineering News
Volume 91 Issue 26 | p. 11 | Concentrates
Issue Date: July 1, 2013

KKR Buys Contract Research Firm PRA

Department: Business
Keywords: drug development, acquisitions, clinical trials

Genstar Capital is selling the contract research firm PRA International to an investment fund managed by Kohlberg Kravis Roberts & Co. Raleigh, N.C.-based PRA provides regulatory and clinical trial development services to pharmaceutical companies. It employs more than 5,300 people at 50 sites. In 2007, Genstar acquired then publicly traded PRA for $797 million and has since expanded the firm. Although the parties involved didn’t disclose a sales price, published reports put it at approximately $1.3 billion.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment